Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors. [electronic resource]
Producer: 20030207Description: 213-8 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Small Cell -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Docetaxel
- Dose-Response Relationship, Drug
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Irinotecan
- Lung Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Taxoids
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.